Hsin-Yi Chang, Carla Saoud, Dianne Torrence, William Tap, Ping Chi, Cristina R Antonescu
求助PDF
{"title":"Alternative driver pathways in peripheral nerve sheath tumors – including DICER1 and/or KRAS alterations","authors":"Hsin-Yi Chang, Carla Saoud, Dianne Torrence, William Tap, Ping Chi, Cristina R Antonescu","doi":"10.1002/path.6391","DOIUrl":null,"url":null,"abstract":"<p><i>DICER1</i>-associated sarcoma is an emerging entity, defined by either somatic or germline dicer 1, ribonuclease III (<i>DICER1</i>) mutations and sharing characteristic morphologic features irrespective of the site of origin. In addition to the <i>DICER1</i> driver mutation, concurrent genomic alterations, including tumor protein 53 (<i>TP53</i>) inactivation and RAS pathway activation, are frequently detected. Tumors that morphologically resemble malignant peripheral nerve sheath tumor (MPNST) have rarely been reported among DICER1 sarcomas and often pose diagnostic challenges. This study was prompted by a case involving morphologic features of MPNST, which harbored co-existing <i>DICER1</i> and hotspot <i>KRAS</i> mutations. Hence, we investigated the incidence of these alterations in PNST from our molecular database compared to the genomic and morphologic spectrum of <i>DICER1</i>-mutant sarcomas. In total, we identified three cases diagnosed as MPNST with co-existing <i>DICER1</i>, ATRX chromatin remodeler (<i>ATRX</i>), and <i>KRAS</i> G12V/A alterations occurring in brain, cerebellopontine angle, and intra-abdominal sites. Two additional cases each of MPNSTs and neurofibromas were identified with hotspot <i>KRAS</i> mutations. All five MPNSTs lacked canonical neurofibromin 1 (<i>NF1</i>)/neurofibromin 2 (<i>NF2</i>) alterations, displaying a classic morphologic appearance with fascicular monomorphic spindle cells and followed a diverse clinical behavior. Among the 38 <i>DICER1</i>-associated sarcomas in our database, eight (21%) had secondary <i>KRAS</i> hotspot mutations, all composed of monomorphic spindle and/or round cells, including three with an MPNST-like histology. In contrast, all 10 (26%) <i>DICER1</i>-mutant sarcomas with <i>TP53</i> mutations showed a pleomorphic phenotype. The DNA-based methylation profile of our index case clustered within the group of sarcomas with <i>DICER1</i> alterations. Our results highlight a small subset of MPNST associated with <i>DICER1</i> and/or <i>KRAS</i> mutations. However, their relationship with conventional MPNST remains to be determined in larger studies. © 2025 The Pathological Society of Great Britain and Ireland.</p>","PeriodicalId":232,"journal":{"name":"The Journal of Pathology","volume":"265 3","pages":"372-384"},"PeriodicalIF":5.6000,"publicationDate":"2025-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of Pathology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/path.6391","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
引用
批量引用
Abstract
DICER1 -associated sarcoma is an emerging entity, defined by either somatic or germline dicer 1, ribonuclease III (DICER1 ) mutations and sharing characteristic morphologic features irrespective of the site of origin. In addition to the DICER1 driver mutation, concurrent genomic alterations, including tumor protein 53 (TP53 ) inactivation and RAS pathway activation, are frequently detected. Tumors that morphologically resemble malignant peripheral nerve sheath tumor (MPNST) have rarely been reported among DICER1 sarcomas and often pose diagnostic challenges. This study was prompted by a case involving morphologic features of MPNST, which harbored co-existing DICER1 and hotspot KRAS mutations. Hence, we investigated the incidence of these alterations in PNST from our molecular database compared to the genomic and morphologic spectrum of DICER1 -mutant sarcomas. In total, we identified three cases diagnosed as MPNST with co-existing DICER1 , ATRX chromatin remodeler (ATRX ), and KRAS G12V/A alterations occurring in brain, cerebellopontine angle, and intra-abdominal sites. Two additional cases each of MPNSTs and neurofibromas were identified with hotspot KRAS mutations. All five MPNSTs lacked canonical neurofibromin 1 (NF1 )/neurofibromin 2 (NF2 ) alterations, displaying a classic morphologic appearance with fascicular monomorphic spindle cells and followed a diverse clinical behavior. Among the 38 DICER1 -associated sarcomas in our database, eight (21%) had secondary KRAS hotspot mutations, all composed of monomorphic spindle and/or round cells, including three with an MPNST-like histology. In contrast, all 10 (26%) DICER1 -mutant sarcomas with TP53 mutations showed a pleomorphic phenotype. The DNA-based methylation profile of our index case clustered within the group of sarcomas with DICER1 alterations. Our results highlight a small subset of MPNST associated with DICER1 and/or KRAS mutations. However, their relationship with conventional MPNST remains to be determined in larger studies. © 2025 The Pathological Society of Great Britain and Ireland.
外周神经鞘肿瘤的替代驱动通路-包括DICER1和/或KRAS改变。
DICER1相关肉瘤是一种新兴的实体,由体细胞或种系DICER1、核糖核酸酶III (DICER1)突变定义,并且与起源部位无关,具有共同的形态学特征。除了DICER1驱动突变外,还经常检测到同步的基因组改变,包括肿瘤蛋白53 (TP53)失活和RAS通路激活。形态学上类似恶性外周神经鞘瘤(MPNST)的肿瘤在DICER1肉瘤中很少报道,并且常常给诊断带来挑战。这项研究是由一个涉及MPNST形态学特征的病例引起的,该病例同时存在DICER1和热点KRAS突变。因此,我们从分子数据库中研究了PNST中这些改变的发生率,并将其与dicer1突变肉瘤的基因组和形态学谱进行了比较。我们总共发现了3例MPNST患者,同时存在DICER1、ATRX染色质重塑子(ATRX)和KRAS G12V/A改变,这些改变发生在大脑、小脑桥脑角和腹内部位。另外两例MPNSTs和神经纤维瘤分别被鉴定为KRAS热点突变。所有5例mpnst均缺乏典型的神经纤维蛋白1 (NF1)/神经纤维蛋白2 (NF2)改变,表现为典型的束状单形梭形细胞形态,临床表现多样。在我们数据库中的38例dicer1相关肉瘤中,8例(21%)有继发性KRAS热点突变,均由单形梭形和/或圆形细胞组成,其中3例具有mpnst样组织学。相比之下,所有10例(26%)伴有TP53突变的dicer1突变肉瘤均表现为多形性表型。我们的索引病例的dna甲基化谱聚集在DICER1改变的肉瘤组中。我们的研究结果突出了与DICER1和/或KRAS突变相关的MPNST的一小部分。然而,它们与传统MPNST的关系仍有待在更大规模的研究中确定。©2025英国和爱尔兰病理学会。
本文章由计算机程序翻译,如有差异,请以英文原文为准。